Clinical study of intracranial hemangioblastoma

JIANG Wu-zhong,LIAO Yu-ping,ZHOU Rong-rong,HONG Ji-dong,HE Yu-xiang,ZHANG Jing,DAI You-yi,姜武忠,廖遇平,周蓉蓉,洪继东,贺玉香,张静,戴幼艺
DOI: https://doi.org/10.3760/j.issn:1004-4221.2006.01.011
2006-01-01
Abstract:Objective To investigate the clinicopathological characteristics of intracranial hemangioblastoma(HB) and its effect with postoperative(subtotal tumor resection) radiotherapy.Methods Sixty-three such patients 38 were analyzed retrospectively.Thirty-eight patients received total tumor resection alone(surgery alone group),the other 25 received subtotal tumor resection plus postoperative radiotherapy(combined treatment group).The most common clinical symptom was intracranial hypertension(35 patients),followed by cerebellar ataxia(20 patients) and cranial nerve injury(8 patients).Eight percent of tumor was located at the cerebellum.Stromal cells woven capillary vascular network featured the tumor under microscopy.Results Five of the 25 patients in the combined group suffered tumor relapse,with a rate of 20%,of whom 4 patients died of recurrence.Six in the 38 patients treated by surgery alone developed relapse,with a rate of 16%,of whom 3 patients died of recurrence.The 5-,10-and 15-year survival rate was 100%,92%,89% in the combined group and 97%,85%,79% in the surgery alone group,respectively.Conclusion Intracranial hemangioblastoma,a benign tumor,mainly occurs in adult,almost always located in the cerebellum.Tumor relapse is the main cause of death.Postoperative radiotherapy can lower the incidence of tumor relapse who have received subtotal tumor resection.
What problem does this paper attempt to address?